Literature DB >> 22565195

Microarray profiling of HepG2 cells ectopically expressing NDRG2.

Xuewu Liu1, Tianshui Niu, Xingping Liu, Wugang Hou, Jing Zhang, Libo Yao.   

Abstract

Previous studies have demonstrated that N-Myc downstream-regulated gene 2 (NDRG2) is a tumor suppressor that is downregulated in many human cancers and when overexpressed, can inhibit tumor growth and metastasis. However, its molecular function, its modulatory targets, and signaling pathways associated with it remain unclear. Here, in an effort to identify the genes modulated by NDRG2 expression, a microarray study was conducted to detect the expression profile of HepG2 cells overexpressing NDRG2 or LacZ. Gene Ontology (GO) biological process analysis revealed that genes related to G protein signaling pathway were upregulated. Five of them were selected and verified by real-time PCR. Gene sets related to M phase of cell cycle were downregulated. This was in agreement with cell cycle analysis. Signaling pathway analysis demonstrated apparent augmented hematopoietic cell lineage pathway and cell adhesion, but reduced glycosylphosphatidylinositol (GPI)-anchor biosynthesis, protein degradation and SNARE interactions. Furthermore, through motif analysis and experimental validation, we found that the p38 phosphorylation can be increased by NDRG2. Our research provides the molecular basis for understanding the role of NDRG2 in tumor cells and raises interesting questions about its mechanisms and potential use in cancer therapy.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22565195     DOI: 10.1016/j.gene.2012.04.044

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  7 in total

1.  The E3 ubiquitin ligase TRIM32 regulates myoblast proliferation by controlling turnover of NDRG2.

Authors:  Ekaterina I Mokhonova; Nuraly K Avliyakulov; Irina Kramerova; Elena Kudryashova; Michael J Haykinson; Melissa J Spencer
Journal:  Hum Mol Genet       Date:  2015-02-20       Impact factor: 6.150

2.  Molecular dissection of Chagas induced cardiomyopathy reveals central disease associated and druggable signaling pathways.

Authors:  Jacob M Wozniak; Tatiana Araújo Silva; Diane Thomas; Jair L Siqueira-Neto; James H McKerrow; David J Gonzalez; Claudia M Calvet
Journal:  PLoS Negl Trop Dis       Date:  2020-05-20

3.  NDRG2 gene expression pattern in ovarian cancer and its specific roles in inhibiting cancer cell proliferation and suppressing cancer cell apoptosis.

Authors:  Fenhong Kang; Yanlong Wang; Yaping Luo; Yongjun Zhang
Journal:  J Ovarian Res       Date:  2020-04-28       Impact factor: 4.234

4.  Clinical Potentials of miR-576-3p, miR-613, NDRG2 and YKL40 in Colorectal Cancer Patients.

Authors:  Manal Nasreddin Eldaly; Fateheya Mohamed Metwally; Wafaa Ghoneim Shousha; Abeer Salah El-Saiid; Shimaa Shawki Ramadan
Journal:  Asian Pac J Cancer Prev       Date:  2020-06-01

5.  Hyperthermia-induced NDRG2 upregulation inhibits the invasion of human hepatocellular carcinoma via suppressing ERK1/2 signaling pathway.

Authors:  Yan Guo; Ji Ma; Lin Wu; Qianrong Wang; Xia Li; Xiaoming Li; Yuan Zhang; Jian Zhang; Libo Yao; Jing Zhang; Wenchao Liu
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

6.  N‑Myc downstream‑regulated gene 2 suppresses the proliferation of T24 human bladder cancer cells via induction of oncosis.

Authors:  Jie Huang; Zhou Wu; Guangxiu Wang; Yingxian Cai; Minshan Cai; Yaozhang Li
Journal:  Mol Med Rep       Date:  2015-08-03       Impact factor: 2.952

Review 7.  Emerging role of N-myc downstream-regulated gene 2 (NDRG2) in cancer.

Authors:  Wei Hu; Chongxi Fan; Peng Jiang; Zhiqiang Ma; Xiaolong Yan; Shouyin Di; Shuai Jiang; Tian Li; Yedong Cheng; Yang Yang
Journal:  Oncotarget       Date:  2016-01-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.